SYY insider notice: 7,351 shares to be sold; prior sales disclosed
Rhea-AI Filing Summary
Form 144 notice for Sysco Corporation (SYY) shows a proposed sale of 7,351 common shares through Fidelity Brokerage Services on 09/02/2025 with an aggregate market value of $595,431. The filer reports acquiring these shares on 09/02/2025 via an option granted on 08/21/2024, and payment is listed as cash. The form also discloses two recent sales by the same person: 37,606 shares sold on 07/23/2025 for $3,046,086 and 6,286 shares sold on 08/13/2025 for $509,166. The filing identifies Fidelity Brokerage Services LLC as the broker and lists the securities exchange as NYSE. The filer certifies no undisclosed material adverse information.
Positive
- Compliance with Rule 144 disclosure is clearly documented, including acquisition and sale details
- Prior insider sales are fully disclosed with dates and gross proceeds, improving transparency
Negative
- Insider sales include significant cash proceeds: $3,046,086 on 07/23/2025 and $509,166 on 08/13/2025 which may be notable to some investors
- Proposed sale represents additional insider liquidity of $595,431 on 09/02/2025
Insights
TL;DR: Routine Rule 144 insider sale notification showing modest proposed disposition and recent prior sales; appears procedural.
The filing documents a proposed sale of 7,351 Sysco common shares valued at $595,431, acquired through an option and to be sold through Fidelity on 09/02/2025. It also reports two recent sales totaling 43,892 shares with gross proceeds of $3,555,252. This provides transparency on insider liquidity events and timing but, standing alone, does not include operational or financial performance metrics to alter valuation assumptions.
TL;DR: Filing meets disclosure requirements; it documents insider sales and includes the required attestation about material non-public information.
The Form 144 supplies required transaction details: acquisition dates, nature of acquisition (option granted 08/21/2024), sale dates, broker, and proceeds for prior sales. The signature attests no undisclosed material adverse information. This record aids governance oversight by documenting timing and method of insider disposals but does not indicate any governance breach by itself.